# Jupiter Life Line Hospitals Ltd (JLHL) > Exchange: NSE | Sector: Pharma | ISIN: ## Price Current Price: ₹1356.6 Day Change: +3.4% 52W High: ₹1625 52W Low: ₹1178 Market Cap: ₹8,773 Cr ## Valuation P/E: 46.47 P/B: 6.04 EPS: ₹28.79 Book Value: ₹221.36 Dividend Yield: 0% ## Returns 1Y Return: -11.04% ## Profitability ROE: 13.39% ROCE: 37.72% Debt/Equity: 0.38 Revenue Growth: 19.9% Profit Growth: 12% EBITDA Margin: 25.01% Operating Margin: 18.91% ## About Jupiter Life Line Hospitals Ltd is a Medical Care Facilities company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place. Sector: Pharma Industry: Medical Care Facilities Sub Industry: Unknown ## Business Model Overview: Jupiter Life Line Hospitals Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Medical Care Facilities. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma. Source: Derived from stock data Revenue Streams: - Domestic formulations - Exports and regulated markets - Specialty or institutional sales Operating Model: - Develops, manufactures, distributes, or services healthcare products across regulated channels. - Approvals, product mix, compliance quality, and R&D productivity shape growth. Recent Context: - Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication - Investor Presentation: Announcement under Regulation 30 (LODR)-Investor Presentation - BSE Filing: Announcement under Regulation 30 (LODR)-Newspaper Publication ## Access Current tier: anonymous More history: Register free to see 3 more years. ## Data Freshness Quote Updated: 2026-05-24T20:00:11.526Z Price History Updated: 2026-05-18T22:58:28.518Z Latest Price History Date: 2026-05-18 Technicals Updated: 2026-05-18T22:58:28.518Z Quant Updated: 2026-05-18T22:58:28.518Z Sentiment Updated: 2026-05-18T22:58:28.518Z Financials Status: current Financials Updated: 2026-05-18T11:31:12.130Z Financials Last Attempt: 2026-05-18T11:31:12.130Z Financials Provider Tried: yahoo Latest P&L Period: FY25 Latest Balance Sheet Period: FY25 Latest Cash Flow Period: FY25 ## P&L (Mar 2021) Revenue: ₹463 Cr Operating Profit: ₹84 Cr (OPM 18%) Net Profit: ₹30 Cr Tax: ₹33 Cr ## Annual P&L History Mar 2021: Rev ₹463Cr | PAT ₹30Cr | OPM 18% Mar 2022: Rev ₹486Cr | PAT ₹-2Cr | OPM 14% Mar 2023: Rev ₹733Cr | PAT ₹51Cr | OPM 21% ## Balance Sheet (Mar 2021) Total Assets: ₹603 Cr Total Liabilities: ₹603 Cr Borrowings: ₹272 Cr Cash: ₹undefined Cr ## Shareholding undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% ## Board - Ajay Pratap Thakker, Chairman & MD - Ankit Ajay Thakker, Joint MD, CEO & Executive Director - Harshad Purani, CFO and President of Administration & Head of Corporate Social Responsibility - Suma Vinayak Upparatti, Company Secretary & Compliance Officer - Neelesh Shinde, Group Chief Technical Officer & Head of Projects --- Source: rupiya.io/stocks/jlhl Disclaimer: For research and education only. Not investment advice.